Correction to “Sequential\nTreatment of Bioresponsive\nNanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes\nwith a CD40 Agonist for Antitumor Immunity”

Correction to “Sequential\nTreatment of Bioresponsive\nNanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes\nwith a CD40 Agonist for Antitumor Immunity”

Publication Details

Journal
Figshare
Published
2024-11-22
DOI
https://doi.org/10.1021/acsnano.4c14105.s001
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction to “Sequential\nTreatment of Bioresponsive\nNanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes\nwith a CD40 Agonist for Antitumor Immunity”

Figshare
Extracellular vesicles in disease
article

Correction to “Sequential\nTreatment of Bioresponsive\nNanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes\nwith a CD40 Agonist for Antitumor Immunity”

article en

Abstract

Correction to “Sequential\nTreatment of Bioresponsive\nNanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes\nwith a CD40 Agonist for Antitumor Immunity”

Figshare
Openalex Percentile: Top 76%
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.